A case discussion Pacemakers and Bradyarrhythmias in Diabetic Mellitus Outcomes of Total Knee Arthroplasty in patients aged 70 years and above An approach to CBC for practitioners Acute cerebral sinus venous thrombosis with different presentations and different outcomes: A case series Diet and nutritional care for DDLT: A case study Vaccine for Dengue (Dengvaxia CYD-TDV) Diagnostic Image Learning from Experience Intra Operative, Chapters 31 and 32 Recommended Readings ATLAS OF HAEMATOLOGY AND HEMATOONCOLOGY Editorial Editorial Board Case reports and Case series: Usefulness of NEWS 2 score in monitoring patients with cytokine storm of COVID-19 pneumonia Treatment approach for extensively Drug-Resistant Tuberculosis (XDR-TB) Modified Lichtenstein mesh repair, for a patient of Coronary Artery Disease, Heart Failure and with Implanted Cardioverter- Defibrillator Fever-induced Brugada Syndrome Pulmonary Thrombo Embolism: When to Thrombolyse
However, diabetics should monitor glucose closely and consult their physician before starting any peptide therapy
### Semaglutide Mechanism of Action Semaglutide achieves **weight loss** through multiple complementary pathways: - **Central appetite suppression** acts on hypothalamic GLP-1 receptors to reduce hunger and increase satiety - **Delayed gastric emptying** slows stomach emptying, prolonging feelings of fullness - **Improved insulin sensitivity** reduces insulin resistance and promotes healthy glucose metabolism - **Reward pathway modulation** reduces cravings and food-seeking behavior by acting on mesolimbic dopamine circuits - **Potential direct effects on adipose tissue** emerging research suggests GLP-1 may directly influence fat metabolism For a complete breakdown of semaglutide's dosing protocol, see our [semaglutide dosing schedule week-by-week guide](/guides/semaglutide-dosing-schedule-week-by-week-guide)
Vitamin D3 Injection (IM/SQ) What It Does: Improves bone health, boosts immunity, and enhances mood by correcting vitamin D deficiencies
This depends on how severe the deficiency was, how well they respond to treatment, and their health
Treatment typically requires intramuscular hydroxocobalamin injections (1 mg three times weekly initially, then every 23 months lifelong) when malabsorption or neurological symptoms are present
